Whalesbook
Toh bhai, ab tak West Bengal apni alag health scheme, Swasthya Sathi chala raha tha. Lekin ab yeh log national AB-PMJAY scheme mein officially aa gaye hain. Iska matlab hai ki eligible logon ko har saal ₹5 Lakh tak ka cashless treatment milega secondary aur tertiary care ke liye. Ye ek bada policy shift hai, jisse healthcare access badhne ki ummeed hai.
Challenges aur Providers ka kya hoga?
Lekin yaar, Swasthya Sathi ko is naye scheme mein integrate karne mein thodi mushkil ho sakti hai. Hospitals mein abhi se logon ki inquiries aa rahi hain. Pichli Swasthya Sathi scheme mein kuch complaints thi jaise payment mein issues aur admission ki limits. Ab jab yeh national scheme apply hogi, toh dekhte hain ki private hospitals ke liye payment terms kaise rahenge. State government ne pehle hi private hospitals ke liye transparency aur cost control ke naye rules laaye hain, toh cheezein thodi complex ho jayengi.
Healthcare Sector Ka Performance
Waise, India ka healthcare sector toh waise bhi mast chal raha hai. Nifty Healthcare Index ne pichle ek saal mein 11.5% ka return diya hai. Is index ka market cap lagbhag ₹20.77 Trillion hai aur P/E ratio 38.5 ke aas-paas hai. West Bengal ke is move se demand badh sakti hai, jiska fayda listed hospital chains aur pharma companies ko ho sakta hai.
Sector Ki Growth Aur Bade Players
India ka healthcare sector itna grow kar raha hai ki 2025 tak $638 Billion tak pahunch jayega! Iska reason hai badhti insurance coverage, government schemes like Ayushman Bharat, aur digital health. Bade players jaise Sun Pharmaceutical Industries (Market Cap ₹4.4 Trillion, P/E 40.18) aur Divi's Laboratories (Market Cap ₹1.79 Trillion, P/E 71.76) ko bhi fayda ho sakta hai. Hospitals mein bhi Apollo Hospitals (Market Cap ₹1.15 Trillion) aur Max Healthcare (Market Cap ₹990 Billion) jaisi companies ko zyada patients milenge.
Risk Bhi Kam Nahi Hai
Lekin yaar, sab kuch itna bhi smooth nahi hone wala. Private hospitals ko AB-PMJAY mein payment rates kam milne ka risk hai, jo pehle Swasthya Sathi mein bhi hua tha. Isse phir se payment aur admission ko lekar disputes ho sakte hain. Yeh scheme logon ka out-of-pocket kharcha kam karegi ya nahi, yeh bhi dekhna hoga, especially jab log private hospitals mein jaate hain. State ke naye cost transparency rules national scheme ke saath clash kar sakte hain. Aur haan, yeh scheme sirf bade treatments par focus karti hai, chote medical needs ko shayad neglect kare. Administrative delays bhi ek badi problem ho sakti hai.
Future Outlook Accha Hai
Overall, India ka healthcare sector toh strong growth dikha raha hai. Government ka bhi support hai, jaise Budget mein Health Ministry ke liye ₹1.06 Lakh Crore se zyada allocate kiye gaye hain. Pharma market toh 2030 tak $130 Billion tak pahunchegi. Bas, yeh sab payment rates, regulations aur smooth implementation par depend karega.